HUMA
HUMA
NASDAQ · Biotechnology

Humacyte Inc

$0.94
+0.05 (+5.88%)
As of Feb 8, 2:06 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 173.28M 180.17M 139.91M
Net Income 5.24M 5.71M 4.80M
EPS
Profit Margin 3.0% 3.2% 3.4%
Rev Growth +9.0% +21.8% +16.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 81.63M 75.78M 80.20M
Total Equity 132.28M 156.42M 129.75M
D/E Ratio 0.62 0.48 0.62
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 9.18M 9.37M 7.10M
Free Cash Flow 6.14M 5.00M 3.87M